Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? | SpringerLink
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
ACE Inhibitor Pathway, Pharmacodynamics
Molecules | Free Full-Text | From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
Choice of drug therapy in primary (essential) hypertension - UpToDate
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Aug 4, 2014: How does naloxone work to reverse the effects of ACE inhibitor toxicity? | Tennessee Poison Center | FREE 24/7 Poison Help Hotline 800.222.1222
Cureus | A Rare Case of Dose-Dependent Losartan-Induced Angioedema
COVID-19 and Use of Drugs Targeting the Renin-Angiotensin-System - American College of Cardiology
ARB might be superior to ACEI for treatment of hypertensive COVID‐19 patients - Zhao - 2021 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports
Frontiers | The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials
ACEIs and ARBs and Their Correlation with COVID-19: A Review | IDR
NKF KDOQI Guidelines
JCI - In-hospital use of ACE inhibitors/angiotensin receptor blockers associates with COVID-19 outcomes in African American patients
Clinical Experience With Angiotensin Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence? | Cardiovascular Diabetology | Full Text
World's Largest Study on ACE Inhibitors, ARBs Shows No Increased Patient Risk of COVID-19 Diagnosis, Complications - Columbia DBMI
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients | eLife
There's just been AKI. So what do we do with the ACEi/ARB? — NephJC
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction? | Circulation
